You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Merck
Mallinckrodt
Boehringer Ingelheim
Moodys
Medtronic

Last Updated: February 17, 2020

DrugPatentWatch Database Preview

Nuvo Pharm Company Profile


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for NUVO PHARM, and when can generic versions of NUVO PHARM drugs launch?

NUVO PHARM has fifteen approved drugs.

There are four US patents protecting NUVO PHARM drugs.

Summary for Nuvo Pharm
US Patents:4
Tradenames:11
Ingredients:11
NDAs:15
Patent Litigation for Nuvo Pharm: See patent lawsuits for Nuvo Pharm

Drugs and US Patents for Nuvo Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nuvo Pharms Inc PENNSAID diclofenac sodium SOLUTION;TOPICAL 020947-001 Nov 4, 2009 DISCN Yes No 8,217,078   Start Trial   Start Trial
Nuvo Pharm DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate TABLET;ORAL 209799-004 Dec 28, 2017 AB RX No No   Start Trial   Start Trial
Nuvo Pharms Inc POLYETHYLENE GLYCOL 3350 polyethylene glycol 3350 FOR SOLUTION;ORAL 206105-001 Oct 28, 2016 OTC No No   Start Trial   Start Trial
Nuvo Pharm DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate TABLET;ORAL 209799-002 Dec 28, 2017 AB RX No No   Start Trial   Start Trial
Nuvo Pharms Inc FOLIC ACID folic acid TABLET;ORAL 204418-001 Jul 28, 2015 AA RX No No   Start Trial   Start Trial
Nuvo Pharm DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate TABLET;ORAL 209799-001 Dec 28, 2017 AB RX No No   Start Trial   Start Trial
Nuvo Pharm FENOFIBRATE fenofibrate TABLET;ORAL 210670-001 Sep 6, 2019 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for NUVO PHARM drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Topical Solution 2.0% ➤ Subscribe 2014-06-03
➤ Subscribe Topical Solution 1.5% ➤ Subscribe 2012-07-11
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Johnson and Johnson
Baxter
AstraZeneca
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.